No Cover Image

Journal article 836 views

The Clinical Candidate VT-1161 Is a Highly Potent Inhibitor of Candida albicans CYP51 but Fails To Bind the Human Enzyme / Andrew Warrilow, C. M. Hull, Josie Parker, E. P. Garvey, W. J. Hoekstra, W. R. Moore, R. J. Schotzinger, Diane Kelly, Steven Kelly, Claire Hull

Antimicrobial Agents and Chemotherapy, Volume: 58, Issue: 12, Pages: 7121 - 7127

Swansea University Authors: Andrew Warrilow, Josie Parker, Diane Kelly, Steven Kelly, Claire Hull

Full text not available from this repository: check for access using links below.

DOI (Published version): 10.1128/AAC.03707-14

Published in: Antimicrobial Agents and Chemotherapy
Published: 2014
URI: https://cronfa.swan.ac.uk/Record/cronfa18693
Tags: Add Tag
No Tags, Be the first to tag this record!
first_indexed 2014-10-14T01:30:03Z
last_indexed 2021-10-27T02:31:43Z
id cronfa18693
recordtype SURis
fullrecord <?xml version="1.0"?><rfc1807><datestamp>2021-10-26T15:38:31.1934352</datestamp><bib-version>v2</bib-version><id>18693</id><entry>2014-10-13</entry><title>The Clinical Candidate VT-1161 Is a Highly Potent Inhibitor of Candida albicans CYP51 but Fails To Bind the Human Enzyme</title><swanseaauthors><author><sid>f066e233e8d0136c9f547b86fa43747f</sid><ORCID>0000-0003-0183-8334</ORCID><firstname>Andrew</firstname><surname>Warrilow</surname><name>Andrew Warrilow</name><active>true</active><ethesisStudent>false</ethesisStudent></author><author><sid>e563ed4e1c7db8d1e131fb78a5f8d0d5</sid><ORCID>0000-0002-3855-4194</ORCID><firstname>Josie</firstname><surname>Parker</surname><name>Josie Parker</name><active>true</active><ethesisStudent>false</ethesisStudent></author><author><sid>5ccf81e5d5beedf32ef8d7c3d7ac6c8c</sid><firstname>Diane</firstname><surname>Kelly</surname><name>Diane Kelly</name><active>true</active><ethesisStudent>false</ethesisStudent></author><author><sid>b17cebaf09b4d737b9378a3581e3de93</sid><ORCID>0000-0001-7991-5040</ORCID><firstname>Steven</firstname><surname>Kelly</surname><name>Steven Kelly</name><active>true</active><ethesisStudent>false</ethesisStudent></author><author><sid>6c495cb489b67bc9bb3f746975c4ff19</sid><firstname>Claire</firstname><surname>Hull</surname><name>Claire Hull</name><active>true</active><ethesisStudent>false</ethesisStudent></author></swanseaauthors><date>2014-10-13</date><deptcode>BMS</deptcode><abstract/><type>Journal Article</type><journal>Antimicrobial Agents and Chemotherapy</journal><volume>58</volume><journalNumber>12</journalNumber><paginationStart>7121</paginationStart><paginationEnd>7127</paginationEnd><publisher/><placeOfPublication/><isbnPrint/><isbnElectronic/><issnPrint/><issnElectronic/><keywords/><publishedDay>1</publishedDay><publishedMonth>12</publishedMonth><publishedYear>2014</publishedYear><publishedDate>2014-12-01</publishedDate><doi>10.1128/AAC.03707-14</doi><url/><notes>E-pub ahead of press.</notes><college>COLLEGE NANME</college><department>Biomedical Sciences</department><CollegeCode>COLLEGE CODE</CollegeCode><DepartmentCode>BMS</DepartmentCode><institution>Swansea University</institution><apcterm/><lastEdited>2021-10-26T15:38:31.1934352</lastEdited><Created>2014-10-13T08:09:46.8460210</Created><path><level id="1">Swansea University Medical School</level><level id="2">Medicine</level></path><authors><author><firstname>Andrew</firstname><surname>Warrilow</surname><orcid>0000-0003-0183-8334</orcid><order>1</order></author><author><firstname>C. M.</firstname><surname>Hull</surname><order>2</order></author><author><firstname>Josie</firstname><surname>Parker</surname><orcid>0000-0002-3855-4194</orcid><order>3</order></author><author><firstname>E. P.</firstname><surname>Garvey</surname><order>4</order></author><author><firstname>W. J.</firstname><surname>Hoekstra</surname><order>5</order></author><author><firstname>W. R.</firstname><surname>Moore</surname><order>6</order></author><author><firstname>R. J.</firstname><surname>Schotzinger</surname><order>7</order></author><author><firstname>Diane</firstname><surname>Kelly</surname><order>8</order></author><author><firstname>Steven</firstname><surname>Kelly</surname><orcid>0000-0001-7991-5040</orcid><order>9</order></author><author><firstname>Claire</firstname><surname>Hull</surname><order>10</order></author></authors><documents/><OutputDurs/></rfc1807>
spelling 2021-10-26T15:38:31.1934352 v2 18693 2014-10-13 The Clinical Candidate VT-1161 Is a Highly Potent Inhibitor of Candida albicans CYP51 but Fails To Bind the Human Enzyme f066e233e8d0136c9f547b86fa43747f 0000-0003-0183-8334 Andrew Warrilow Andrew Warrilow true false e563ed4e1c7db8d1e131fb78a5f8d0d5 0000-0002-3855-4194 Josie Parker Josie Parker true false 5ccf81e5d5beedf32ef8d7c3d7ac6c8c Diane Kelly Diane Kelly true false b17cebaf09b4d737b9378a3581e3de93 0000-0001-7991-5040 Steven Kelly Steven Kelly true false 6c495cb489b67bc9bb3f746975c4ff19 Claire Hull Claire Hull true false 2014-10-13 BMS Journal Article Antimicrobial Agents and Chemotherapy 58 12 7121 7127 1 12 2014 2014-12-01 10.1128/AAC.03707-14 E-pub ahead of press. COLLEGE NANME Biomedical Sciences COLLEGE CODE BMS Swansea University 2021-10-26T15:38:31.1934352 2014-10-13T08:09:46.8460210 Swansea University Medical School Medicine Andrew Warrilow 0000-0003-0183-8334 1 C. M. Hull 2 Josie Parker 0000-0002-3855-4194 3 E. P. Garvey 4 W. J. Hoekstra 5 W. R. Moore 6 R. J. Schotzinger 7 Diane Kelly 8 Steven Kelly 0000-0001-7991-5040 9 Claire Hull 10
title The Clinical Candidate VT-1161 Is a Highly Potent Inhibitor of Candida albicans CYP51 but Fails To Bind the Human Enzyme
spellingShingle The Clinical Candidate VT-1161 Is a Highly Potent Inhibitor of Candida albicans CYP51 but Fails To Bind the Human Enzyme
Andrew, Warrilow
Josie, Parker
Diane, Kelly
Steven, Kelly
Claire, Hull
title_short The Clinical Candidate VT-1161 Is a Highly Potent Inhibitor of Candida albicans CYP51 but Fails To Bind the Human Enzyme
title_full The Clinical Candidate VT-1161 Is a Highly Potent Inhibitor of Candida albicans CYP51 but Fails To Bind the Human Enzyme
title_fullStr The Clinical Candidate VT-1161 Is a Highly Potent Inhibitor of Candida albicans CYP51 but Fails To Bind the Human Enzyme
title_full_unstemmed The Clinical Candidate VT-1161 Is a Highly Potent Inhibitor of Candida albicans CYP51 but Fails To Bind the Human Enzyme
title_sort The Clinical Candidate VT-1161 Is a Highly Potent Inhibitor of Candida albicans CYP51 but Fails To Bind the Human Enzyme
author_id_str_mv f066e233e8d0136c9f547b86fa43747f
e563ed4e1c7db8d1e131fb78a5f8d0d5
5ccf81e5d5beedf32ef8d7c3d7ac6c8c
b17cebaf09b4d737b9378a3581e3de93
6c495cb489b67bc9bb3f746975c4ff19
author_id_fullname_str_mv f066e233e8d0136c9f547b86fa43747f_***_Andrew, Warrilow
e563ed4e1c7db8d1e131fb78a5f8d0d5_***_Josie, Parker
5ccf81e5d5beedf32ef8d7c3d7ac6c8c_***_Diane, Kelly
b17cebaf09b4d737b9378a3581e3de93_***_Steven, Kelly
6c495cb489b67bc9bb3f746975c4ff19_***_Claire, Hull
author Andrew, Warrilow
Josie, Parker
Diane, Kelly
Steven, Kelly
Claire, Hull
author2 Andrew Warrilow
C. M. Hull
Josie Parker
E. P. Garvey
W. J. Hoekstra
W. R. Moore
R. J. Schotzinger
Diane Kelly
Steven Kelly
Claire Hull
format Journal article
container_title Antimicrobial Agents and Chemotherapy
container_volume 58
container_issue 12
container_start_page 7121
publishDate 2014
institution Swansea University
doi_str_mv 10.1128/AAC.03707-14
college_str Swansea University Medical School
hierarchytype
hierarchy_top_id swanseauniversitymedicalschool
hierarchy_top_title Swansea University Medical School
hierarchy_parent_id swanseauniversitymedicalschool
hierarchy_parent_title Swansea University Medical School
department_str Medicine{{{_:::_}}}Swansea University Medical School{{{_:::_}}}Medicine
document_store_str 0
active_str 0
published_date 2014-12-01T03:29:22Z
_version_ 1718456431898787840
score 10.844586